Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M92,292Revenue $M7,670Net Margin (%)26.1Z-Score7.2
Enterprise Value $M91,617EPS $2.4Operating Margin %32.8F-Score8
P/E(ttm))48.1Cash Flow Per Share $4.4Pre-tax Margin (%)30.3Higher ROA y-yY
Price/Book14.210-y EBITDA Growth Rate %0Quick Ratio4.4Cash flow > EarningsY
Price/Sales12.65-y EBITDA Growth Rate %23.1Current Ratio4.6Lower Leverage y-yN
Price/Cash Flow17.9y-y EBITDA Growth Rate %39.3ROA % (ttm)13.3Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)36.7Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M801ROI % (ttm)17.8Gross Margin Increase y-yY

Gurus Latest Trades with CELG

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CELGRonald Muhlenkamp 2014-12-31 Reduce-1.03%$86.38 - $118.68
($105.53)
$ 117.2310%Reduce -41.31%86,240
CELGJohn Hussman 2014-12-31 Sold Out -0.2%$86.38 - $118.68
($105.53)
$ 117.2310%Sold Out0
CELGJoel Greenblatt 2014-12-31 Buy 0.01%$86.38 - $118.68
($105.73)
$ 117.2310%New holding10,259
CELGGeorge Soros 2014-09-30 Sold Out -0.45%$83.13 - $96.21
($90.29)
$ 117.2323%Sold Out0
CELGJohn Hussman 2014-09-30 Buy 0.2%$83.13 - $96.21
($90.29)
$ 117.2323%New holding25,000
CELGJoel Greenblatt 2014-09-30 Sold Out -0.07%$83.13 - $96.21
($90.29)
$ 117.2323%Sold Out0
CELGKen Fisher 2014-09-30 Add0.02%$83.13 - $96.21
($90.29)
$ 117.2323%Add 77.12%232,137
CELGRonald Muhlenkamp 2014-06-30 Reduce-1.91%$68.45 - $86.8
($75.89)
$ 117.2335%Reduce -51.74%144,140
CELGGeorge Soros 2014-06-30 Buy 0.45%$68.45 - $86.8
($75.89)
$ 117.2335%New holding688,000
CELGRay Dalio 2014-06-30 Sold Out -0.08%$68.45 - $86.8
($75.89)
$ 117.2335%Sold Out0
CELGJoel Greenblatt 2014-06-30 Buy 0.07%$68.45 - $86.8
($75.89)
$ 117.2335%New holding63,980
CELGJohn Burbank 2014-06-30 Sold Out -0.01%$68.45 - $86.8
($75.89)
$ 117.2335%Sold Out0
CELGKen Fisher 2014-06-30 Add0.01%$68.45 - $86.8
($75.89)
$ 117.2335%Add 75.59%131,064
CELGJohn Keeley 2014-03-31 Sold Out $69.65 - $85.97
($79.51)
$ 117.2332%Sold Out0
CELGJohn Hussman 2013-09-30 Sold Out -0.31%$60.13 - $77.31
($70.14)
$ 117.2340%Sold Out0
CELGKen Heebner 2013-06-30 Sold Out -0.79%$56.1 - $65.09
($60.18)
$ 117.2349%Sold Out0
CELGAndreas Halvorsen 2013-06-30 Sold Out -0.3%$56.1 - $65.09
($60.18)
$ 117.2349%Sold Out0
CELGJoel Greenblatt 2013-06-30 Sold Out -0.01%$56.1 - $65.09
($60.18)
$ 117.2349%Sold Out0
CELGRay Dalio 2013-03-31 Sold Out -0.07%$39.24 - $57.96
($50.79)
$ 117.2357%Sold Out0
CELGJohn Hussman 2011-12-31 Sold Out -0.3%$30.12 - $34.01
($32.2)
$ 117.2373%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CELG is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


CELG: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KAPLAN GILLADirector 2015-02-26Sell15,000$122.89-4.26view
CASEY MICHAEL DDirector 2015-02-25Sell15,000$123.19-4.49view
KARSEN PERRY Asee remarks 2015-02-11Sell27,896$120.12-2.05view
Alles Mark JSee Remarks 2015-02-06Sell117,099$120.68-2.5view
STEIN LAWRENCE VSee Remarks 2015-01-15Sell26,666$120.01-1.96view
KAPLAN GILLADirector 2015-01-02Sell45,536$113.473.69view
Daniel Thomas Osee remarks 2014-12-15Sell30,000$115.062.26view
KAPLAN GILLADirector 2014-12-08Sell15,000$118.2-0.46view
Daniel Thomas Osee remarks 2014-11-24Sell33,818$110.276.7view
KARSEN PERRY Asee remarks 2014-11-12Sell39,420$107.239.73view

Press Releases about CELG :

    Quarterly/Annual Reports about CELG:

    News about CELG:

    Articles On GuruFocus.com
    February Pick Of Biotech Stocks Feb 17 2015 
    Celleration Acquisition Just the Start of Alliqua’s M&A Strategy Feb 04 2015 
    J.P. Morgan Chimes In With Ratings On BioTech Stocks Jan 06 2015 
    UPDATE: Bionor Pharma Announces That the Combination of Vacc-4x + Revlimid(R) Is Well Tolerated and Nov 18 2014 
    Bionor Pharma Announces That the Combination of Vacc-4x + Revlimid(R) Is Safe and Increases CD4 Coun Nov 17 2014 
    Three Attractively Priced Small Cap Biotech Stocks Nov 05 2014 
    Weekly 52-Week Highs Highlight: ALL, SRE, CLX, CELG Oct 06 2014 
    Ken Fisher's Top Increases of the First Quarter Apr 22 2014 
    David Winters' 2013 Letter to Wintergreen Fund Shareholders Mar 05 2014 
    You Can No Longer Ignore Biotech Feb 07 2014 


    More From Other Websites
    Does Celgene Have Another Blockbuster on the Way? Mar 26 2015
    Agios' PK Deficiency Drug AG-348 Gets Orphan Drug Status - Analyst Blog Mar 26 2015
    Biotech's rough ride over? Mar 26 2015
    3 Biotech Stocks Bucking Short Interest Trends Mar 26 2015
    Midday Glance: Biotechnology companies Mar 26 2015
    Midday Glance: Biotechnology companies Mar 26 2015
    A Bold Call on Biotech ETFs Mar 26 2015
    MorphoSys Plunges Most Since 2002 After Ending Pact With Celgene Mar 26 2015
    Biotech Stock Selloff: Is It Justified? Mar 26 2015
    Early Glance: Biotechnology companies Mar 26 2015
    Early Glance: Biotechnology companies Mar 26 2015
    Biotech Crash -- How Long Will It Last? Mar 26 2015
    The Biotech Selloff: It's Déjà Vu All Over Again Mar 26 2015
    'Fast Money' Recap: The 3 Reasons Stocks Tanked Wednesday Mar 26 2015
    Trading the selloff: 8 stocks to buy Mar 25 2015
    Biotech's biggest threat Mar 25 2015
    Trading the selloff: 8 stocks to buy Mar 25 2015
    Celgene (CELG) Stock Declines Today as Bubble Fears Grow Mar 25 2015
    Worries Bubble About Biotech Mar 25 2015
    Biotechs On Track For Worst Week In A Year Mar 25 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK